Breaking News, Collaborations & Alliances

Applied StemCell, CIRM Partner on Resources for Regenerative Therapies

To provide access to clinical-grade iPSCs and gene editing technologies to accelerate development.

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

Applied StemCell, Inc. (ASC) and the California Institute for Regenerative Medicine (CIRM) have partnered as Industry Resource Partners. ASC is offering its IP-based gene insertion technology and TARGATT iPSC master cell line, along with resources to support cell therapy process development and GMP manufacturing, to CIRM Translational and Clinical awardees. Award recipients will gain access to Applied StemCell’s newly expanded GMP clean room suites dedicated to iPSC, MSC, and cell manufacturing,...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters